After the completion of the study, we measured serum allergen-specific IgE sensitization in the EAT participants and demonstrated in an intention-to-treat analysis that the intervention successfully reduced the development of food allergy among EIG infants who were sensitized on specific IgE testing at enrollment. The gene discussed is IGHE; the disease is food allergy.